| Label | Id | |
|---|---|---|
| clinical manifestations of COVID-19 | Condition | |
| co morbid | Condition | |
| co morbid conditions | Condition | |
| independently | Condition | |
| In vitro | Condition | |
| in vitro | Condition | |
| multiple co morbid conditions | Condition | |
| On cells | Condition | |
| symptomatic | Condition | |
| Symptomatic presentation of COVID-19 | Condition | |
| TxA2 increases significantly | Condition |
